The use of Perspex-based devices in patient specific quality assurance of Acuros XB plans
Physical and Engineering Sciences in Medicine · 2026
DOI: 10.1007/s13246-026-01779-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical and Engineering Sciences in Medicine, 2026. Verfasst von Ali N Noon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Network, WSLHD, Blacktown Cancer and Haematology Centre, 18 Blacktown Road, Sydney, NSW, 2148, Australia. Ali.Noon@health.nsw.gov.…. Hauptthemen laut MEDLINE: Quality Assurance, Health Care, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
A transition from the dose-to-water algorithm AAA to the dose-to-medium algorithm Acuros XB (AXB) presents challenges for comparison with measurements made in the dose-to-water calibrated ArcCHECK. This study evaluates the implications of this transition on patient-specific quality assurance (PSQA) measurements. A modified dose-medium calibration for the ArcCHECK to was introduced to address these limitations, by developing a formalism to compare ionisation chamber measurements to water-like plastics such as Perspex to AXB dose-to-medium calculations. A retrospective analysis was conducted on 40 VMAT plans: 5 prostate, 5 cervix, 10 head/neck, 10 lung (5 standard VMAT, 5 SBRT), and 10 breast. Plans were recalculated in AXB using a Perspex-assigned ArcCHECK phantom and compared with dose-to-water and dose-to-medium calibrated ArcCHECK measurements with a γ (3%,2 mm) criteria. Only one of 35 non-SBRT AXB dose-to-medium plans was within clinical tolerance during dose-to-water calibrated ArcCHECK comparisons, compared to 33 of 35 AAA dose-to-water plans. Applying the proposed dose-to-medium calibration improved results, with 30 of 35 AXB plans performing within tolerance. In the SBRT lung cases, no AXB dose-to-medium plans passed ArcCHECK gamma comparisons, compared to four out of five AAA plans. Applying the dose-to-medium calibration to the ArcCHECK did not improve the passing rates, suggesting limitations of AXB calculations on the ArcCHECK device. This study highlights the inadequacy of dose-to-water calibrated PSQA devices for verifying AXB dose-to-medium calculations and demonstrates practical solutions, including applying a dose-to-medium calibration for the ArcCHECK for AXB PSQA applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiation Oncology Network, WSLHD, Blacktown Cancer and Haematology Centre, 18 Blacktown Road, Sydney, NSW, 2148, Australia. Ali.Noon@health.nsw.gov.au.
- Institute of Medical Physics, University of Sydney, Sydney, NSW, 2006, Australia. Ali.Noon@health.nsw.gov.au.
- Radiation Oncology Network, WSLHD, Blacktown Cancer and Haematology Centre, 18 Blacktown Road, Sydney, NSW, 2148, Australia.
- Institute of Medical Physics, University of Sydney, Sydney, NSW, 2006, Australia.
Zitieren
APA
Noon, A. N., Truant, D., Junis, I., & Barber, J. (2026). The use of Perspex-based devices in patient specific quality assurance of Acuros XB plans. Physical and Engineering Sciences in Medicine. https://doi.org/10.1007/s13246-026-01779-3
Vancouver
Noon AN, Truant D, Junis I, Barber J. The use of Perspex-based devices in patient specific quality assurance of Acuros XB plans. Physical and Engineering Sciences in Medicine. 2026. doi:10.1007/s13246-026-01779-3
BibTeX
@article{Noon2026,
author = {Noon, Ali N and Truant, Daniel and Junis, Izabela and Barber, Jeffrey},
title = {The use of Perspex-based devices in patient specific quality assurance of Acuros XB plans},
journal = {Physical and Engineering Sciences in Medicine},
year = {2026},
doi = {10.1007/s13246-026-01779-3}
}
EUVIMED